Solvonis advances PTSD drug program with new compounds
Solvonis Therapeutics PLC has made progress in developing new treatments for post-traumatic stress disorder (PTSD). The London-based company has completed…
Solvonis Therapeutics PLC has made progress in developing new treatments for post-traumatic stress disorder (PTSD). The London-based company has completed…
The Depression Drugs Market is projected to experience substantial growth from 2025 to 2032, according to a new report by…